| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 1312805
[patent_doc_number] => 06610660
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-08-26
[patent_title] => 'O2-arylated or O2-glycosylated 1-substituted diazen-1-ium-1,2-diolates and O2-substituted 1-(2-carboxylato) pyrrolidin-1-yl diazen-1-ium-1,2-diolates'
[patent_app_type] => B1
[patent_app_number] => 09/254301
[patent_app_country] => US
[patent_app_date] => 1999-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 20703
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 178
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/610/06610660.pdf
[firstpage_image] =>[orig_patent_app_number] => 09254301
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/254301 | O2-arylated or O2-glycosylated 1-substituted diazen-1-ium-1,2-diolates and O2-substituted 1-(2-carboxylato) pyrrolidin-1-yl diazen-1-ium-1,2-diolates | May 2, 1999 | Issued |
Array
(
[id] => 4383415
[patent_doc_number] => 06277852
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-08-21
[patent_title] => 'Piperazinyl 5-HT1 agonists and antagonists'
[patent_app_type] => 1
[patent_app_number] => 9/291352
[patent_app_country] => US
[patent_app_date] => 1999-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12491
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 584
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/277/06277852.pdf
[firstpage_image] =>[orig_patent_app_number] => 291352
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/291352 | Piperazinyl 5-HT1 agonists and antagonists | Apr 13, 1999 | Issued |
Array
(
[id] => 4320348
[patent_doc_number] => 06248740
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-06-19
[patent_title] => 'Condensed pyridazine derivatives, their production and use'
[patent_app_type] => 1
[patent_app_number] => 9/284362
[patent_app_country] => US
[patent_app_date] => 1999-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 58912
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/248/06248740.pdf
[firstpage_image] =>[orig_patent_app_number] => 284362
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/284362 | Condensed pyridazine derivatives, their production and use | Apr 13, 1999 | Issued |
Array
(
[id] => 4304671
[patent_doc_number] => 06187780
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-02-13
[patent_title] => 'Assymetrically substituted xanthine derivatives having adenosine A1 antagonistic activity'
[patent_app_type] => 1
[patent_app_number] => 9/287372
[patent_app_country] => US
[patent_app_date] => 1999-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13952
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 238
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/187/06187780.pdf
[firstpage_image] =>[orig_patent_app_number] => 287372
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/287372 | Assymetrically substituted xanthine derivatives having adenosine A1 antagonistic activity | Apr 6, 1999 | Issued |
Array
(
[id] => 4406992
[patent_doc_number] => 06232314
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-05-15
[patent_title] => 'Arylalkylpiperazine compounds as antioxidants'
[patent_app_type] => 1
[patent_app_number] => 9/180258
[patent_app_country] => US
[patent_app_date] => 1999-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14762
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 204
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/232/06232314.pdf
[firstpage_image] =>[orig_patent_app_number] => 180258
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/180258 | Arylalkylpiperazine compounds as antioxidants | Mar 17, 1999 | Issued |
Array
(
[id] => 4349973
[patent_doc_number] => 06214816
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-04-10
[patent_title] => 'Heterocyclic compounds'
[patent_app_type] => 1
[patent_app_number] => 9/266236
[patent_app_country] => US
[patent_app_date] => 1999-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8171
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 235
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/214/06214816.pdf
[firstpage_image] =>[orig_patent_app_number] => 266236
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/266236 | Heterocyclic compounds | Mar 9, 1999 | Issued |
Array
(
[id] => 4409729
[patent_doc_number] => 06172224
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-01-09
[patent_title] => 'Process for isolating 2-amino-6-chloro-9-[(1\'S,2\'R)-1\'2\'-bis(hydroxymethyl)-cyclopropane-1\'-YL]m ethylpurine and an optical isomer thereof'
[patent_app_type] => 1
[patent_app_number] => 9/263999
[patent_app_country] => US
[patent_app_date] => 1999-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4383
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 165
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/172/06172224.pdf
[firstpage_image] =>[orig_patent_app_number] => 263999
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/263999 | Process for isolating 2-amino-6-chloro-9-[(1'S,2'R)-1'2'-bis(hydroxymethyl)-cyclopropane-1'-YL]m ethylpurine and an optical isomer thereof | Mar 7, 1999 | Issued |
Array
(
[id] => 4187784
[patent_doc_number] => 06160112
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-12-12
[patent_title] => 'Procedure for the preparation of dioxopenicillanic acid derivatives'
[patent_app_type] => 1
[patent_app_number] => 9/261236
[patent_app_country] => US
[patent_app_date] => 1999-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2823
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 121
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/160/06160112.pdf
[firstpage_image] =>[orig_patent_app_number] => 261236
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/261236 | Procedure for the preparation of dioxopenicillanic acid derivatives | Mar 2, 1999 | Issued |
Array
(
[id] => 1300431
[patent_doc_number] => 06624177
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-09-23
[patent_title] => 'Matrix metalloproteinase inhibitors and their therapeutic uses'
[patent_app_type] => B1
[patent_app_number] => 09/254384
[patent_app_country] => US
[patent_app_date] => 1999-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10231
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 188
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/624/06624177.pdf
[firstpage_image] =>[orig_patent_app_number] => 09254384
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/254384 | Matrix metalloproteinase inhibitors and their therapeutic uses | Mar 1, 1999 | Issued |
Array
(
[id] => 4409696
[patent_doc_number] => 06265396
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-07-24
[patent_title] => '.beta.-lactam compounds and process for preparing the same'
[patent_app_type] => 1
[patent_app_number] => 9/254175
[patent_app_country] => US
[patent_app_date] => 1999-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5983
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 130
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/265/06265396.pdf
[firstpage_image] =>[orig_patent_app_number] => 254175
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/254175 | .beta.-lactam compounds and process for preparing the same | Mar 1, 1999 | Issued |
| 09/242950 | CARBAPENEM ANTIBACTERIAL COMPOUNDS, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS OF TREATMENT | Feb 24, 1999 | Abandoned |
Array
(
[id] => 4396673
[patent_doc_number] => 06297232
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-10-02
[patent_title] => 'Triazolo[4,5-D]pyrimidinyl derivatives and their use as medicaments'
[patent_app_type] => 1
[patent_app_number] => 9/011992
[patent_app_country] => US
[patent_app_date] => 1999-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29515
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 481
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/297/06297232.pdf
[firstpage_image] =>[orig_patent_app_number] => 011992
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/011992 | Triazolo[4,5-D]pyrimidinyl derivatives and their use as medicaments | Feb 18, 1999 | Issued |
Array
(
[id] => 1521787
[patent_doc_number] => 06414141
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-07-02
[patent_title] => 'Process for purifying an ampicillin pro-drug ester'
[patent_app_type] => B1
[patent_app_number] => 09/230476
[patent_app_country] => US
[patent_app_date] => 1999-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4014
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/414/06414141.pdf
[firstpage_image] =>[orig_patent_app_number] => 09230476
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/230476 | Process for purifying an ampicillin pro-drug ester | Jan 25, 1999 | Issued |
| 09/214476 | PYRAZINE DERIVATIVES AND THEIR USE FOR MATERIAL AND PLANT PROTECTION | Jan 20, 1999 | Abandoned |
| 09/214802 | PROCESS OF PREPARATION OF VALACYCLOVIR AND RELEVANT INTERMEDIATES | Jan 11, 1999 | Abandoned |
Array
(
[id] => 1494575
[patent_doc_number] => 06342501
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-01-29
[patent_title] => 'Pyrrolo2,3-d pyrimidines as antiviral agents'
[patent_app_type] => B1
[patent_app_number] => 09/229391
[patent_app_country] => US
[patent_app_date] => 1999-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23241
[patent_no_of_claims] => 51
[patent_no_of_ind_claims] => 20
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/342/06342501.pdf
[firstpage_image] =>[orig_patent_app_number] => 09229391
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/229391 | Pyrrolo2,3-d pyrimidines as antiviral agents | Jan 10, 1999 | Issued |
Array
(
[id] => 4157741
[patent_doc_number] => 06156745
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-12-05
[patent_title] => '2.beta.-substituted-6-alkylidene penicillanic acid derivatives as .beta.-lactamase inhibitors'
[patent_app_type] => 1
[patent_app_number] => 9/223077
[patent_app_country] => US
[patent_app_date] => 1998-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 18090
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 528
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/156/06156745.pdf
[firstpage_image] =>[orig_patent_app_number] => 223077
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/223077 | 2.beta.-substituted-6-alkylidene penicillanic acid derivatives as .beta.-lactamase inhibitors | Dec 28, 1998 | Issued |
| 09/221016 | ELECTROPHILIC KETONES FOR THE TREATMENT OF HERPESVIRUS INFECTIONS | Dec 22, 1998 | Abandoned |
Array
(
[id] => 4356197
[patent_doc_number] => 06200967
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-03-13
[patent_title] => 'Anticoagulant agents'
[patent_app_type] => 1
[patent_app_number] => 9/202626
[patent_app_country] => US
[patent_app_date] => 1998-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15989
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/200/06200967.pdf
[firstpage_image] =>[orig_patent_app_number] => 202626
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/202626 | Anticoagulant agents | Dec 16, 1998 | Issued |
Array
(
[id] => 4288532
[patent_doc_number] => 06211191
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-04-03
[patent_title] => 'Integrin receptor antagonists'
[patent_app_type] => 1
[patent_app_number] => 9/212510
[patent_app_country] => US
[patent_app_date] => 1998-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27671
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 4680
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/211/06211191.pdf
[firstpage_image] =>[orig_patent_app_number] => 212510
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/212510 | Integrin receptor antagonists | Dec 14, 1998 | Issued |